Analyst (Cambridge UK) 2015-09-21

Single molecule array (Simoa) assay with optimal antibody pairs for cytokine detection in human serum samples.

Danlu Wu, Milena Dumont Milutinovic, David R Walt

Index: Analyst 140 , 6277-82, (2015)

Full Text: HTML

Abstract

Concentrations of cytokines in bodily fluids reflect the physiological or pathological state of the patient and can be used for prognosis, disease diagnosis or for monitoring therapeutic efficacy. However, in the bodily fluids of healthy or sub-healthy individuals, many cytokines are present at concentrations that are near or below the detection limits of current methods. Here we selected antibody pairs to be employed in the single molecule array (Simoa) assay for ten cytokines including GM-CSF, TNF-α, IFN-γ, IL-1β, IL-2, IL-4, IL-5, IL-6, IL-7, and IL-10. The limits of detection (LODs) obtained were as low as 90 aM-6 fM. These assays allow detection of cytokines in healthy human serum samples at levels significantly below the detection limits of conventional ELISA assays. We provide detailed antibody pair information as well as the concentration profiles of ten cytokines in healthy human serum to serve as reference data for further ultrasensitive immunoassay development and future clinical applications.


Related Compounds

  • 1-(3-Dimethylamino...
  • Ethanol
  • Hydrochloric acid
  • Magnesium choride
  • Trometamol hydroch...
  • Ethylenediaminetet...
  • MES

Related Articles:

Minimizing the non-specific binding of nanoparticles to the brain enables active targeting of Fn14-positive glioblastoma cells.

2015-02-01

[Biomaterials 42 , 42-51, (2014)]

Altering in vivo macrophage responses with modified polymer properties.

2015-07-01

[Biomaterials 56 , 187-97, (2015)]

Species-dependent binding of new synthesized bicalutamide analogues to albumin by optical biosensor analysis.

2015-01-01

[J. Pharm. Biomed. Anal. 111 , 324-32, (2015)]

Herceptin conjugated PLGA-PHis-PEG pH sensitive nanoparticles for targeted and controlled drug delivery.

2015-06-20

[Int. J. Pharm. 487 , 81-90, (2015)]

Development of poly (I:C) modified doxorubicin loaded magnetic dendrimer nanoparticles for targeted combination therapy.

2014-10-01

[Biomed. Pharmacother. 68(8) , 979-87, (2014)]

More Articles...